Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglaret

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
The Lancet. Global Health|October 14, 2017
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trialAnani Badje, Raoul Moh, Delphine Gabillard, et al.
The Journal of Infectious Diseases|February 22, 2019
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational StudyRomy Kerber, Eva Lorenz, Sophie Duraffour, et al.
The New England Journal of Medicine|July 21, 2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa, Christine Danel, Raoul Moh, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Plos Medicine|April 6, 2016
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Plos Medicine|March 2, 2016
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.
The Lancet. Global Health|October 14, 2017
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trialAnani Badje, Raoul Moh, Delphine Gabillard, et al.
The Journal of Infectious Diseases|February 22, 2019
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational StudyRomy Kerber, Eva Lorenz, Sophie Duraffour, et al.
The New England Journal of Medicine|July 21, 2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa, Christine Danel, Raoul Moh, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Plos Medicine|April 6, 2016
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Plos Medicine|March 2, 2016
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaDaouda Sissoko, Cedric Laouenan, Elin Folkesson, et al.
Pageof 27